Pizzuti Dana bought CRNX
March 4, 2024 · Form 4 insider transaction
Pizzuti Dana bought 87,000 shares of Crinetics Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
87,000
Price
$0.00
Total value
N/A
InsiderPizzuti Dana
RoleOfficer
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateMarch 4, 2024
Filing dateMarch 6, 2024
Shares owned after87,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The stock option shall vest and become exercisable in a series of forty-eight (48) successive equal monthly installments measured from the vesting commencement date of March 4, 2024.